Literature DB >> 23011536

Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Driss Ait Ouakrim1, Trevor Lockett, Alex Boussioutas, Louise Keogh, Louisa B Flander, Ingrid Winship, Graham G Giles, John L Hopper, Mark A Jenkins.   

Abstract

PURPOSE: Australia has one of the highest incidences of colorectal cancer (CRC) in the world. In 2006, the federal government introduced a screening program consisting of a one-off fecal occult blood test offered to people turning 50, 55, or 65 years. We conducted a population-based study to estimate CRC screening practices existing outside the current program.
METHODS: A total of 1887 unaffected subjects categorized "at or slightly above average risk" of CRC were selected from the Australasian Colorectal Cancer Family Registry. We calculated the proportions of participants that reported appropriate, under- and over-screening according to national guidelines. We performed a logistic regression analysis to evaluate associations between over-screening and a set of socio-demographic factors.
RESULTS: Of 532 participants at average risk of CRC, eligible for screening, 4 (0.75 %) reported appropriate screening, 479 (90 %) reported never having been screened, 18 (3 %) reported some but less than appropriate screening, and 31 (6 %) reported over-screening. Of 412 participants aged 50 years or over, slightly above average risk of CRC, 1 participant (0.25 %) reported appropriate screening, 316 (77 %) reported no screening, and 11 (3 %) reported some but less than appropriate screening. Among participants under age 50 years, 2 % of those at average risk and 10 % of those slightly above average risk reported over-screening. Middle-aged people, those with a family history of CRC and those with a university degree, were more likely to be over-screened.
CONCLUSION: Overall, the level of CRC screening participation was low and the vast majority of screening tests undertaken were inappropriate in terms of timing, modality, or frequency.

Entities:  

Mesh:

Year:  2012        PMID: 23011536      PMCID: PMC3508400          DOI: 10.1007/s10552-012-0067-y

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  34 in total

1.  Inappropriate colorectal cancer screening: findings and implications.

Authors:  Deborah A Fisher; Latisha Judd; Nadia S Sanford
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

2.  Making sense of differing bowel cancer screening guidelines.

Authors:  Hooi C Ee; John K Olynyk
Journal:  Med J Aust       Date:  2009-04-06       Impact factor: 7.738

Review 3.  Population-based screening for colorectal cancer: Australian research and implementation.

Authors:  Graeme P Young
Journal:  J Gastroenterol Hepatol       Date:  2009-10       Impact factor: 4.029

Review 4.  Colorectal cancer screening barriers and facilitators in older persons.

Authors:  Idris Guessous; Chiranjeev Dash; Pauline Lapin; Mary Doroshenk; Robert A Smith; Carrie N Klabunde
Journal:  Prev Med       Date:  2009-12-16       Impact factor: 4.018

5.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

6.  Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.

Authors:  Marianne F Weber; Emily Banks; Robyn Ward; Freddy Sitas
Journal:  J Med Screen       Date:  2008       Impact factor: 2.136

7.  Colorectal cancer test use from the 2005 National Health Interview Survey.

Authors:  Jean A Shapiro; Laura C Seeff; Trevor D Thompson; Marion R Nadel; Carrie N Klabunde; Sally W Vernon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

8.  Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.

Authors:  Paul Ritvo; Ronald Myers; M Elisabeth Del Giudice; Lawrence Pazsat; Michelle Cotterchio; Roberta Howlett; Verna Mai; Patrick Brown; Terrence Sullivan; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

Review 9.  Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States.

Authors:  Hind A Beydoun; May A Beydoun
Journal:  Cancer Causes Control       Date:  2007-12-18       Impact factor: 2.506

10.  Predictors of endoscopic colorectal cancer screening over time in 11 states.

Authors:  Lee Mobley; Tzy-Mey Kuo; Matthew Urato; John Boos; Nancy Lozano-Gracia; Luc Anselin
Journal:  Cancer Causes Control       Date:  2009-11-28       Impact factor: 2.506

View more
  6 in total

1.  Exploring a novel method for optimising the implementation of a colorectal cancer risk prediction tool into primary care: a qualitative study.

Authors:  Shakira Milton; Jon D Emery; Jane Rinaldi; Joanne Kinder; Adrian Bickerstaffe; Sibel Saya; Mark A Jenkins; Jennifer McIntosh
Journal:  Implement Sci       Date:  2022-05-12       Impact factor: 7.960

2.  The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.

Authors:  Jennifer G Walker; Adrian Bickerstaffe; Nadira Hewabandu; Sanjay Maddumarachchi; James G Dowty; Mark Jenkins; Marie Pirotta; Fiona M Walter; Jon D Emery
Journal:  BMC Med Inform Decis Mak       Date:  2017-01-19       Impact factor: 2.796

3.  Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.

Authors:  Mary Dillon; Louisa Flander; Daniel D Buchanan; Finlay A Macrae; Jon D Emery; Ingrid M Winship; Alex Boussioutas; Graham G Giles; John L Hopper; Mark A Jenkins; Driss Ait Ouakrim
Journal:  PLoS Med       Date:  2018-08-16       Impact factor: 11.069

4.  Cost-effectiveness of family history-based colorectal cancer screening in Australia.

Authors:  Driss A Ouakrim; Alex Boussioutas; Trevor Lockett; John L Hopper; Mark A Jenkins
Journal:  BMC Cancer       Date:  2014-04-16       Impact factor: 4.430

5.  Can a print-based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial.

Authors:  Mariko Carey; Robert Sanson-Fisher; Finlay Macrae; Emilie Cameron; David Hill; Catherine D'Este; Jody Simmons; Christopher Doran
Journal:  Aust N Z J Public Health       Date:  2016-09-13       Impact factor: 2.939

6.  The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Authors:  Jennifer G Walker; Finlay Macrae; Ingrid Winship; Jasmeen Oberoi; Sibel Saya; Shakira Milton; Adrian Bickerstaffe; James G Dowty; Richard De Abreu Lourenço; Malcolm Clark; Louise Galloway; George Fishman; Fiona M Walter; Louisa Flander; Patty Chondros; Driss Ait Ouakrim; Marie Pirotta; Lyndal Trevena; Mark A Jenkins; Jon D Emery
Journal:  Trials       Date:  2018-07-25       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.